← United States · Coverage record
US · SEC FORM 4
Nuvalent, Inc.
NUVL · — · CIK 0001861560 · Healthcare
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
110 Form 4 transaction lines observed in the same window
39 sales · 71 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 10 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-11-03 · DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2022-11-03 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | Purchase (P) | Class A Common Stock | 650,000 | USD 33.50 | USD 21,775,000 | SEC filing ↗ |
| 2022-11-03 | Hack Andrew A. F. | Purchase (P) | Class A Common Stock | 149,253 | USD 33.50 | USD 4,999,976 | SEC filing ↗ |
| 2021-08-02 | Hack Andrew A. F. | Purchase (P) | Class A Common Stock | 735,000 | USD 17.00 | USD 12,495,000 | SEC filing ↗ |
Form 4 evidence
274 transaction lines in the latest 365-day window; 895 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC filing ↗ |
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD 124.00 | USD 427,056 | SEC filing ↗ |
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | D (D) | Class A Common Stock | 8,949,225 | USD 124.00 | USD 1,109,703,900 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC filing ↗ |
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD 124.00 | USD 427,056 | SEC filing ↗ |
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | D (D) | Class A Common Stock | 8,949,225 | USD 124.00 | USD 1,109,703,900 | SEC filing ↗ |
| 2026-07-15 | Wheeler Cameron | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC filing ↗ |
| 2026-07-15 | Wheeler Cameron | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Turner Christopher Durant | U (U) | Class A Common Stock | 31,530 | USD 124.00 | USD 3,909,720 | SEC filing ↗ |
| 2026-07-15 | Turner Christopher Durant | D (D) | Class A Common Stock - Restricted Stock Units | 41,100 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Turner Christopher Durant | D (D) | Class A Common Stock - Performance Stock Units | 14,350 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Turner Christopher Durant | Award / grant (A) | Class A Common Stock - Performance Stock Units | 14,350 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-15 | Srivastava Sapna | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC filing ↗ |
| 2026-07-15 | Srivastava Sapna | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Squarer Ron | D (D) | Class A Common Stock - Restricted Stock Units | 6,281 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Protopapas Anna | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC filing ↗ |
| 2026-07-15 | Protopapas Anna | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Porter James Richard | U (U) | Class A Common Stock | 203,529 | USD 124.00 | USD 25,237,596 | SEC filing ↗ |
| 2026-07-15 | Porter James Richard | D (D) | Class A Common Stock - Restricted Stock Units | 121,350 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Porter James Richard | D (D) | Class A Common Stock - Performance Stock Units | 40,025 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Porter James Richard | Award / grant (A) | Class A Common Stock - Performance Stock Units | 40,025 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-15 | Pelish Henry E. | U (U) | Class A Common Stock | 22,393 | USD 124.00 | USD 2,776,732 | SEC filing ↗ |
| 2026-07-15 | Pelish Henry E. | D (D) | Class A Common Stock - Restricted Stock Units | 41,100 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Pelish Henry E. | D (D) | Class A Common Stock - Performance Stock Units | 14,350 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Pelish Henry E. | Award / grant (A) | Class A Common Stock - Performance Stock Units | 14,350 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-15 | Oliger Christy J. | U (U) | Class A Common Stock | 1,324 | USD 124.00 | USD 164,176 | SEC filing ↗ |
| 2026-07-15 | Oliger Christy J. | D (D) | Class A Common Stock - Restricted Stock Units | 6,091 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Noci Darlene | U (U) | Class A Common Stock | 17,017 | USD 124.00 | USD 2,110,108 | SEC filing ↗ |
| 2026-07-15 | Noci Darlene | D (D) | Class A Common Stock - Restricted Stock Units | 41,100 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Noci Darlene | D (D) | Class A Common Stock - Performance Stock Units | 14,350 | USD — | USD — | SEC filing ↗ |
| 2026-07-15 | Noci Darlene | Award / grant (A) | Class A Common Stock - Performance Stock Units | 14,350 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-15 | Miller Deborah Ann | U (U) | Class A Common Stock | 18,534 | USD 124.00 | USD 2,298,216 | SEC filing ↗ |
| 2026-07-15 | Miller Deborah Ann | D (D) | Class A Common Stock - Restricted Stock Units | 41,100 | USD — | USD — | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | NUVL |
| CIK | 0001861560 |
| Sector | Healthcare |
| Industry | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | — |
Data coverage
| Local Form 4 history | 895 transaction lines from 2021-08-02 to 2026-07-15 3 P purchase lines · 585 S sale lines · 307 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.